Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-07-16 01:17 | 2014-07-14 | PCI | N/A | GROSS WILLIAM H | Other | Other | BUY | $23.58 | 99,550 | $2,347,051 | 2,182,379 | +4.8% |
| 2014-07-16 00:45 | 2014-07-11 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $316.80 | 300,000 | $95,038,620 | 22,075,741 | +1.4% |
| 2014-07-15 04:06 | 2014-07-10 | CMCT | Creative Media & Community Trust Corp | RESSLER RICHARD S | Director, 10% owner | Real Estate Investment Trusts | BUY | $24.86 | 104,400 | $2,595,457 | 322,324 | +47.9% |
| 2014-07-15 04:07 | 2014-07-10 | CMCT | Creative Media & Community Trust Corp | Kuba Shaul | Director, 10% owner | Real Estate Investment Trusts | BUY | $24.86 | 104,400 | $2,595,457 | 322,324 | +47.9% |
| 2014-07-15 04:07 | 2014-07-10 | CMCT | Creative Media & Community Trust Corp | Shemesh Avraham | Director, 10% owner | Real Estate Investment Trusts | BUY | $24.86 | 104,400 | $2,595,457 | 322,324 | +47.9% |
| 2014-07-15 04:06 | 2014-07-10 | CMCT | Creative Media & Community Trust Corp | CIM Service Provider, LLC | Other | Real Estate Investment Trusts | BUY | $24.86 | 104,400 | $2,595,457 | 322,324 | +47.9% |
| 2014-07-15 00:46 | 2014-07-10 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $311.08 | 175,000 | $54,439,070 | 21,775,741 | +0.8% |
| 2014-07-12 00:44 | 2014-06-30 | TPH | Tri Pointe Homes, Inc. | Black Diamond Arbitrage Offshore Ltd. | 10% owner | Operative Builders | BUY | $15.51 | 1,148,849 | $17,820,371 | 4,235,030 | +37.2% |
| 2014-07-11 23:19 | 2014-07-09 | SIR | N/A | PORTNOY ADAM | Director, 10% owner | Other | BUY | $31.51 | 225,000 | $7,089,750 | 247,393 | +1,004.8% |
| 2014-07-11 23:20 | 2014-07-09 | SIR | N/A | PORTNOY BARRY M | Director, 10% owner | Other | BUY | $31.51 | 275,000 | $8,665,250 | 302,369 | +1,004.8% |
| 2014-07-12 00:28 | 2014-07-10 | PCI | N/A | GROSS WILLIAM H | Other | Other | BUY | $23.61 | 147,601 | $3,485,420 | 2,082,829 | +7.6% |
| 2014-07-11 04:20 | 2014-07-08 | PHH | N/A | Citadel GP LLC | 10% owner | Other | BUY | $23.85 | 513,780 | $12,254,115 | 0 | +100.0% |
| 2014-07-11 00:45 | 2014-07-08 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $309.76 | 348,000 | $107,798,046 | 21,600,741 | +1.6% |
| 2014-07-11 04:29 | 2014-06-30 | TPH | Tri Pointe Homes, Inc. | CARLSON CAPITAL L P | 10% owner | Operative Builders | BUY | $15.51 | 1,148,849 | $17,820,371 | 4,235,030 | +37.2% |
| 2014-07-10 03:03 | 2014-07-07 | NERV | Minerva Neurosciences, Inc. | De Rubertis Francesco | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,620,833 | $9,724,998 | 5,285,638 | +44.2% |
| 2014-07-10 02:56 | 2014-07-07 | NERV | Minerva Neurosciences, Inc. | Pellegrini Lorenzo | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 737,500 | $4,425,000 | 3,883,212 | +23.4% |
| 2014-07-10 02:52 | 2014-07-07 | NERV | Minerva Neurosciences, Inc. | Care Capital III LLC | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 737,500 | $4,425,000 | 3,883,212 | +23.4% |
| 2014-07-10 03:00 | 2014-07-07 | NERV | Minerva Neurosciences, Inc. | Ollier Michele | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,620,833 | $9,724,998 | 5,285,638 | +44.2% |
| 2014-07-10 03:02 | 2014-07-07 | NERV | Minerva Neurosciences, Inc. | Index Venture Associates III Ltd | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,620,833 | $9,724,998 | 5,285,638 | +44.2% |
| 2014-07-09 23:26 | 2014-07-08 | PCI | N/A | GROSS WILLIAM H | Other | Other | BUY | $23.67 | 101,444 | $2,400,733 | 1,935,228 | +5.5% |
| 2014-07-10 00:29 | 2014-07-08 | GBIM | N/A | MORGENTHALER PARTNERS VII LP | 10% owner | Other | BUY | $10.00 | 130,000 | $1,300,000 | 530,461 | +32.5% |
| 2014-07-08 23:26 | 2014-07-08 | GBIM | N/A | Celgene International Inc | 10% owner | Other | BUY | $10.00 | 200,000 | $2,000,000 | 600,670 | +49.9% |
| 2014-07-09 00:42 | 2014-07-03 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $312.37 | 356,700 | $111,422,736 | 21,252,741 | +1.7% |
| 2014-07-09 00:48 | 2014-07-08 | GBIM | N/A | HEALTHCARE VENTURES VII LP | 10% owner | Other | BUY | $10.00 | 190,000 | $1,900,000 | 584,267 | +48.2% |
| 2014-07-08 03:49 | 2014-07-02 | FURX | N/A | Forest Laboratories, LLC | 10% owner | Other | BUY | $95.00 | 11,169,066 | $1,061,061,270 | 0 | +100.0% |
| 2014-07-08 00:46 | 2014-06-30 | POSC-OB | POSITRON CORP | Rooney Patrick G | Director, Officer, 10% owner - Chief Executive Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $0.00 | 277,777,777 | $1,000,000 | 733,159,595 | +61.0% |
| 2014-07-04 02:40 | 2014-05-16 | RVEN | N/A | King Apex Group Holdings IV Ltd | 10% owner | Other | BUY | $0.20 | 29,500,000 | $5,900,000 | 43,000,000 | +218.5% |
| 2014-07-03 21:55 | 2014-07-01 | GNRC | GENERAC HOLDINGS INC. | FMR LLC | 10% owner, Other | Motors & Generators | BUY | $47.04 | 27,168 | $1,277,983 | 763,071 | +3.7% |
| 2014-07-04 01:00 | 2014-07-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $307.25 | 212,400 | $65,259,560 | 20,896,041 | +1.0% |
| 2014-07-04 00:46 | 2014-07-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $300.20 | 212,400 | $63,761,418 | 20,683,641 | +1.0% |
| 2014-07-02 17:11 | 2014-07-01 | N/A | N/A | Wagner David Lynn | Other | Other | BUY | $10.00 | 250,000 | $2,500,000 | 250,000 | +100.0% |
| 2014-07-02 17:07 | 2014-07-01 | N/A | N/A | Blitz Adam | Other | Other | BUY | $10.00 | 250,000 | $2,500,000 | 250,000 | +100.0% |
| 2014-07-02 23:30 | 2014-06-30 | MERC | MERCER INTERNATIONAL INC. | KELLOGG PETER R | 10% owner | Pulp Mills | BUY | $10.48 | 147,000 | $1,540,457 | 2,006,431 | +7.9% |
| 2014-07-02 04:01 | 2014-02-28 | CANV | CV Sciences, Inc. | Mona Michael III | Officer - VP of Operations | Pharmaceutical Preparations | BUY | $1.00 | 1,000,000 | $1,000,000 | 2,250,000 | +80.0% |
| 2014-07-01 21:51 | 2014-06-27 | NEP | XPLR Infrastructure, LP | ROBO JAMES L | Director, Officer - Chairman & CEO of GP | Electric Services | BUY | $28.68 | 143,576 | $4,117,903 | 143,576 | +100.0% |
| 2014-07-01 17:56 | 2014-06-30 | FOLD | AMICUS THERAPEUTICS, INC. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $3.50 | 4,000,000 | $14,000,000 | 12,339,444 | +48.0% |
| 2014-07-02 00:39 | 2014-06-27 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $281.17 | 262,400 | $73,779,559 | 20,471,241 | +1.3% |
| 2014-07-01 23:37 | 2014-06-27 | RSG | REPUBLIC SERVICES, INC. | CASCADE INVESTMENT LLC | 10% owner | Refuse Systems | BUY | $37.85 | 356,417 | $13,489,599 | 93,400,230 | +0.4% |
| 2014-03-31 20:58 | 2014-03-27 | PFSI | N/A | COOPERMAN LEON G | 10% owner | Other | BUY | $15.99 | 632,000 | $10,105,680 | 1,276,700 | +98.0% |
| 2014-04-01 02:47 | 2013-10-29 | RVEN | N/A | Bai Xiaofan | Director, 10% owner | Other | BUY | $0.20 | 20,000,000 | $4,000,000 | 75,000,000 | +36.4% |
| 2014-04-01 00:43 | 2014-03-27 | DXLG | DESTINATION XL GROUP, INC. | MESDAG WILLEM | Director, 10% owner | Retail-Family Clothing Stores | BUY | $5.66 | 1,598,100 | $9,044,767 | 7,522,354 | +27.0% |
| 2014-04-01 01:22 | 2014-03-28 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $306.73 | 306,945 | $94,149,577 | 20,018,090 | +1.6% |
| 2014-04-01 01:21 | 2014-03-27 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $311.01 | 306,945 | $95,463,977 | 19,711,145 | +1.6% |
| 2014-03-31 16:06 | 2014-03-27 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $25.72 | 243,001 | $6,249,986 | 243,001 | +100.0% |
| 2014-04-01 00:07 | 2014-03-28 | DAVE | N/A | Pleasant Lake Partners LLC | 10% owner | Other | BUY | $25.00 | 50,000 | $1,250,000 | 840,410 | +6.3% |
| 2014-03-28 21:53 | 2014-03-26 | OXBRU | OXBRIDGE RE HOLDINGS Ltd | MARTIN ALLAN S. | Director | Fire, Marine & Casualty Insurance | BUY | $6.00 | 204,000 | $1,224,000 | 39,000 | +100.0% |
| 2014-03-28 21:54 | 2014-03-26 | OXBRU | OXBRIDGE RE HOLDINGS Ltd | CABILLOT RAYMOND E | Director | Fire, Marine & Casualty Insurance | BUY | $6.00 | 412,625 | $2,475,750 | 412,625 | +100.0% |
| 2014-03-29 01:46 | 2014-03-26 | VSAR | Aravive, Inc. | AKKARAJU SRINIVAS | Director, 10% owner | Pharmaceutical Preparations | BUY | $21.00 | 60,000 | $1,260,000 | 2,146,978 | +2.9% |
| 2014-03-29 02:30 | 2014-03-27 | VSAR | Aravive, Inc. | New Leaf Ventures II, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $21.02 | 60,000 | $1,261,200 | 3,371,930 | +1.8% |
| 2014-03-28 23:37 | 2014-03-26 | LMNR | Limoneira CO | COLE LECIL E | Director | Agricultural Production-Crops | BUY | $22.73 | 50,000 | $1,136,390 | 59,521 | +525.2% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.